Evaluation of autologous and allogeneic T cell-based therapies in ex-vivo and in-vivo xenograft tumor models

被引:0
|
作者
Liu, Sherry
Borroel, Jasmine
Sunico, Carmen
Eastwood, Emily
Corcoran, Bridget
Carapia, Bianca
Sperry, Jantzen
Nakashima, Jonathan
Shrimali, Rajeev
机构
关键词
D O I
10.1158/1538-7445.AM2024-5342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5342
引用
收藏
页数:2
相关论文
共 50 条
  • [21] In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation
    Busca, Alessandro
    Aversa, Franco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (11) : 1401 - 1415
  • [22] Eradication of mantle cell lymphoma (MCL) from autografts after in-vivo and ex-vivo purging.
    Andersen, NS
    Pedersen, L
    Kolstad, A
    Jonsson, A
    Elonen, E
    Geisler, CH
    BLOOD, 1998, 92 (10) : 648A - 648A
  • [23] EFFECTS OF AMMONIUM PERFLUOROOCTANOATE ON LEYDIG-CELL FUNCTION - IN-VITRO, IN-VIVO, AND EX-VIVO STUDIES
    BIEGEL, LB
    LIU, RCM
    HURTT, ME
    COOK, JC
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 134 (01) : 18 - 25
  • [24] VISCOSITY MATCHING POSITIVELY AFFECTS THE CORRELATION OF PRESSURE-VOLUME LOOPS BETWEEN IN-VIVO AND EX-VIVO MODELS
    Schinstock, Emma
    Kudlik, D'Anne
    Eggen, Michael
    Iaizzo, Paul A.
    PROCEEDINGS OF THE 2021 DESIGN OF MEDICAL DEVICES CONFERENCE (DMD2021), 2021,
  • [25] INTRAMURAL DELIVERY OF MARKER AGENT IN EX-VIVO AND IN-VIVO MODELS USING A NOVEL DRUG-DELIVERY SLEEVE
    KAPLAN, AV
    KERMODE, J
    GRANT, G
    KLEIN, E
    VETTE, RJ
    HINOHARA, T
    SIMPSON, JB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A187 - A187
  • [26] Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study
    Eldeeb, Alaa Emad
    Salah, Salwa
    Ghorab, Mahmoud
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 52 : 236 - 247
  • [27] Utilization of propranolol hydrochloride mucoadhesive invasomes as a locally acting contraceptive: in-vitro, ex-vivo, and in-vivo evaluation
    Teaima, Mahmoud H.
    Eltabeeb, Moaz A.
    El-Nabarawi, Mohamed A.
    Abdellatif, Menna M.
    DRUG DELIVERY, 2022, 29 (01) : 2549 - 2560
  • [28] Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model
    Schaefer, Edo
    Liao, Yanling
    Anderson-Crannage, Morgan
    Hochberg, Bruno
    Mouehla, Hanif
    Pan, Jian
    Fallon, Bernadette
    Ayello, Janet
    Cairo, Mitchell S.
    BLOOD, 2022, 140 : 8641 - 8642
  • [29] The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell committee
    Oved, Joseph H.
    Russell, Athena
    Dezern, Amy
    Prockop, Susan E.
    Bonfim, Carmem
    Sharma, Akshay
    Purtill, Duncan
    Lakkaraja, Madhavi
    Bidgoli, Alan
    Bhoopalan, Senthil Velan
    Soni, Sandeep
    Boelens, Jaap Jan
    Abraham, Allistair
    CYTOTHERAPY, 2025, 27 (01) : 78 - 84
  • [30] Ex-vivo Autologous Haematopoietic Stem Cell Gene Therapy in Mucopolysaccharidosis Type IIIA
    Kinsella, Jane
    Jones, Simon
    Church, Heather
    Jones, Ceri
    Ellison, Stuart
    Booth, Claire
    Buckland, Karen
    Rico, Diego Leon
    Bigger, Brian
    Thrasher, Adrian J.
    Wynn, Robert
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 320 - 320